Teva Pharmaceutical Industries Ltd Company Profile (NYSE:TEVA)

Analyst Ratings

Consensus Ratings for Teva Pharmaceutical Industries Ltd (NYSE:TEVA) (?)
Ratings Breakdown: 5 Hold Rating(s), 21 Buy Rating(s)
Consensus Rating:Buy (Score: 2.81)
Consensus Price Target: $70.44 (28.70% upside)

Analysts' Ratings History for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Show:
DateFirmActionRatingPrice TargetActions
7/20/2016RBC Capital MarketsReiterated RatingOutperform$71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2016HSBCUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2016MizuhoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2016Goldman Sachs Group Inc.Lower Price Target$70.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2016Piper Jaffray Cos.Reiterated RatingNeutral$58.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Oppenheimer Holdings Inc.Lower Price TargetOutperform$77.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Jefferies GroupLower Price TargetBuy$72.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Citigroup Inc.Reiterated RatingBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Credit Suisse Group AGReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Leerink SwannReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Deutsche Bank AGLower Price TargetBuy$80.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Morgan StanleyReiterated RatingOverweight$71.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016GuggenheimReiterated RatingBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Bank of America Corp.Reiterated RatingBuy$82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016BTIG ResearchReiterated RatingBuy$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016Sanford C. BernsteinReiterated RatingOutperform$43.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016Nomura Holdings Inc.Reiterated RatingNeutral$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/21/2016ArgusReiterated RatingBuy$82.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/27/2015Berenberg BankLower Price TargetHold$72.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$75.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015Standpoint ResearchBoost Price TargetBuy$78.00 -> $84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2015Cowen and CompanyReiterated RatingOutperform$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015GabelliReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Barclays PLCBoost Price TargetOverweight$70.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015CRT CapitalBoost Price TargetBuy$67.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Sterne Agee CRTSet Price TargetBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2014ING GroupInitiated CoveragePositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Evercore ISIInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/9/2016Q116$1.17$1.20$4.78 billion$4.81 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2016Q415$1.29$1.28$4.83 billion$4.88 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$1.28$1.35$4.75 billion$4.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$1.31$1.43$4.90 billion$4.97 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$1.26$1.36$4.84 billion$5.00 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015Q414$1.31$1.31$5.17 billion$5.17 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$1.23$1.32$5.09 billion$5.06 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214$1.21$1.23$5.08 billion$5.00 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$1.22$1.22$5.11 million$5.00 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q413$1.26$1.42$5.19 billion$5.40 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313$1.26$1.27$5.00 billion$5.06 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q213$1.20$1.20$4.94 billion$4.90 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q113$1.10$1.12$4.85 billion$4.90 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2013Q412$1.33$1.32$5.26 billion$5.20 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$1.25$1.28$5.08 billion$5.00 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$1.28$1.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2012$1.44$1.47ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2012$1.58$1.59ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2011$1.22$1.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2011$1.08$1.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2011$1.03$1.04ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2011$1.28$1.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Current Dividend Information for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Annual Dividend:$1.16
Dividend Yield:2.12%
Payout Ratio:21.89% (Based on Current Year Consensus EPS Estimate)
19.37% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:13.00% (3 Year Average)

Dividend History for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/9/2016quarterly$0.345/20/20165/24/20166/7/2016Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Quarterly$0.292/25/20162/29/20163/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015quarterly$0.3411/13/201511/17/201512/3/2015Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015quarterly$0.348/18/20158/20/20159/3/2015Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015special$0.342.25%5/15/20155/19/20156/4/2015Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015quarterly$0.342.36%2/17/20152/19/20153/3/2015Tweet This Announcement  Share This Announcement on StockTwits
10/31/2014special$0.322.43%11/13/201411/17/201412/2/2014Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014quarterly$0.352.61%8/19/20148/21/20149/4/2014Tweet This Announcement  Share This Announcement on StockTwits
5/2/2014quarterly$0.352.77%5/16/20145/20/20146/2/2014Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014$0.342/20/20142/24/20143/10/2014Tweet This Announcement  Share This Announcement on StockTwits
11/1/2013quarterly$0.333.51%11/18/201311/20/201312/2/2013Tweet This Announcement  Share This Announcement on StockTwits
8/5/2013quarterly$0.323.34%8/16/20138/20/20139/3/2013Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013quarterly$0.328/20/20139/2/2013Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013special$0.323.28%5/16/20135/20/20136/3/2013Tweet This Announcement  Share This Announcement on StockTwits
2/8/2013quarterly$0.313.21%2/19/20132/21/20133/7/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
DateHeadline
07/23/16 10:32 AMA Look at the Stock Strength for Teva Pharmaceutical Industries Limited (NYSE:TEVA) - Engelwood Daily
07/23/16 10:32 AMStock Focus: Following Analyst Expectations on Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - Engelwood Daily
07/23/16 10:32 AMPerformance watch list: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - News Oracle
07/23/16 10:32 AMFitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'
07/22/16 06:35 PMStock Focus: Following Analyst Expectations on Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/22/16 06:35 PMAre Analysts Still Saying "Buy" this Stock: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/22/16 06:35 PMUpdate on Teva Pharmaceutical Industries Limited (NYSE:TEVA) for the day - Twin County News
07/22/16 09:43 AMTakeda Said to Explore Sale of Chemicals Unit to Raise Cash (2)
07/22/16 09:31 AMInvestors scrap for Teva Pharmaceutical bonds - [Reuters] - Teva Pharmaceutical raised more than US$20bn across three currencies this week via an acquisition-driven bond that took advantage of pent-up demand for corporate paper in a yield-starved market. Investors had been making space for the well-telegraphed deal ever since Teva announced its US$40.5bn acquisition of Allergan Generics earlier in the year, while declining rates across the developed world and a lack of recent supply in the US and European markets added impetus to the transaction. In Europe, Teva issued bonds that priced up to 35bp inside its secondary curve - and those outstanding bonds, in turn, tightened by an incredible 40bp during the execution process.
07/21/16 07:08 PMTeva Sells Additional $5.4B In Bonds To Buy Allergan Unit
07/21/16 07:08 PMTeva Gets Funding to Close Allergan Deal With Franc Bond Sale
07/21/16 07:08 PMTeva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
07/21/16 07:08 PMEarnings Focus and Crowd Sourced Sentiment Review for Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/21/16 09:35 AMStocks Preparing To Gain Concentrations- M&T Bank (NYSE:MTB), F5 Networks (NASDAQ:FFIV), Teva Pharmaceutical ... - Seneca Globe
07/21/16 09:35 AMJefferies Maintains Teva Pharmaceutical Industries Ltd (ADR) to Buy with Price Target $69.00 - TheFounders Daily
07/21/16 09:35 AMTeva raises €4b in European bond offering
07/21/16 09:35 AMTeva Announces Pricing of Additional €4.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
07/21/16 09:35 AMFitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB'
07/21/16 04:08 AMTeva Markets Swiss-Franc Bonds in Worldwide Fundraising Sweep -
07/20/16 07:48 PMAnalysts Holding Strong to their Buy Rating on: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/20/16 07:48 PMOption Market: Teva Pharmaceutical Industries Limited Risk Hits A Substantially Lowered Level - CML News
07/20/16 07:48 PMIs Teva Pharmaceutical Industries Limited(NYSE: TEVA), a large market cap stock a smart buy? - The Daily Leicester
07/20/16 09:41 AMTeva Pharmaceutical Industries Limited (NYSE:TEVA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 09:41 AMSell-side Value Play with Decent Upside: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/20/16 09:41 AMTrader Observing Stocks: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Rock Creek Pharmaceuticals, Inc ... - Street Updates
07/20/16 09:41 AMTrending Analyst Recommended Stock: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - News Oracle
07/20/16 01:10 AM2:10 am Teva Pharma prices $15 bln of Senior Notes across 6 tranches -
07/19/16 06:57 PMTeva Sells $15 Billion of Bonds
07/19/16 06:57 PMTeva corporate bond deal could become year’s 3rd biggest
07/19/16 10:57 AMTeva (TEVA) Stock Down After Pricing in Debt Offering -
07/19/16 07:45 AMTeva Pharmaceutical : Sells $15 Billion of Bonds
07/19/16 07:45 AMTeva Finalizes Bond Sale
07/19/16 07:45 AMTeva Pharma prices $15 bln in notes to fund Allergan generics deal
07/19/16 07:45 AMMaxim Group Reiterates "Buy" Rating for Teva Pharmaceutical Industries Ltd (TEVA)
07/19/16 07:45 AMAnalysts Pounding the Table on Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/19/16 07:45 AMTeva prices notes to fund Allergan deal - Seeking Alpha
07/19/16 07:45 AMHC Stocks News Alerts: Endo International plc (NASDAQ:ENDP), Teva Pharmaceutical Industries Ltd (ADR) (NYSE ... - share market updates (press release)
07/19/16 06:54 AM'Incredible' Demand for Teva's $15B Bond Deal Pushes Yields Lower -
07/18/16 09:05 AMWestRock Co (NYSE:WRK) & Teva Pharmaceutical Industries (NYSE:TEVA) Stocks to Track - Money News (press release)
07/18/16 06:57 AMTeva Pharmaceutical Industries Ltd -- Moody's assigns Baa2 stable to Teva's bond offering -
07/17/16 06:06 PMAnalysts Are Expecting this Stock to Rise: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - TGP
07/17/16 09:15 AMAllergan : Teva Pharmaceutical Industries Ltd. $40B Deal With Allergan Plc , To Conclude Any Time
07/16/16 09:56 AMGoldman Sachs Sees 'Limited Upside' In Teva Regardless Of Acquisition Results
07/15/16 12:03 PMInvestors Trading Alert: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Bristol-Myers Squibb Company (NYSE ... - Street Updates
07/15/16 12:03 PMHC Stocks Reports: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Inovio Pharmaceuticals Inc (NASDAQ:INO) - share market updates (press release)
07/15/16 12:03 PMRecommendation Trends for Investors: Teva Pharmaceutical Industries Limited (NYSE:TEVA) - News Oracle
07/15/16 12:03 PMMerck & Co. Inc versus Teva Pharmaceutical Industries Limited Head to Head Compare - CML News
07/15/16 12:03 PMTeva Pharmaceutical Industries Ltd (ADR), Allergan Near To Be One - Business Finance News
07/15/16 12:03 PMTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) $40B Deal With Allergan Plc (NYSE:AGN), To Conclude “Any Time” - Market Exclusive
07/15/16 12:03 PMPhRMA Welcomes Five New Member Companies

Social

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd logoTeva Pharmaceutical Industries Limited is a global pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. It has a global portfolio of approximately 1,000 molecules. Its central nervous system (CNS) portfolio includes Copaxone for the treatment of multiple sclerosis, Azilect for the treatment of the symptoms of Parkinson's disease and Nuvigil for the treatment of sleep disorders, as well as several therapies for the treatment of pain care. Its main respiratory medicines include ProAir hydrofluoroalkane, QVAR and Duoresp Spiromax. Its oncology portfolio includes Treanda, Trisenox, Granix Synribo in the United States and Lonquex, Tevagrastim/Ratiograstim, Myocet, Trisenox and Eporatio outside the United States. Its women's health portfolio includes ParaGard, Plan B One-Step OTC/Rx (levonorgestrel) and Zoely.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: TEVA
  • CUSIP:
Key Metrics:
  • Previous Close: $54.63
  • 50 Day Moving Average: $52.31
  • 200 Day Moving Average: $55.48
  • P/E Ratio: 28.37
  • P/E Growth: 1.98
  • Market Cap: $50.02B
  • Beta: 0.82
  • Current Year EPS Consensus Estimate: $5.30 EPS
  • Next Year EPS Consensus Estimate: $5.99 EPS
Additional Links:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Chart for Saturday, July, 23, 2016